David is a surgeon scientist who specialises in the treatment of malignant pancreatic diseases. His research focus is on the development and implementation of novel therapeutic strategies for pancreatic cancer in particularly around DNA-damage response deficiency, by utilising molecular biomarkers of prognosis and therapeutic responsiveness.
David undertook his pancreatic surgical fellowship, PhD, and post-doctoral training in Australia, and was recruited to University of Glasgow in 2013 as part of an initiative to implement precision medicine in West of Scotland and the UK.
He co-leads Precision-Panc, a pan-UK initiative to deliver personalised cancer care for pancreatic cancer, and is the Chief Investigator of the Master Protocol.
David is involved in Precision Promise, a Pancreatic Cancer Action Network (USA) initiative dedicated in delivering personalized treatment for patients with pancreatic cancer. David contributes to ICGC ARGO, aiming to shape the future of the next generation cancer genomic projects to ultimately realise the goals and promises of precision medicine.
David is also an Honorary Consultant Pancreatic Surgeon at Glasgow Royal Infirmary as part of West of Scotland Pancreatic Unit that serves as tertiary pancreatic referral centre for the West of Scotland. His clinical research aim is to shorten the distance between the bench and the clinic to ensure meaningful and seamless translation between the two.
We are looking for highly motivated and innovative individuals to join our team of pioneering researchers.Join The Team